University of Dundee

Latest News

June 2019

  • Dr Samantha Budd Haeberlein with Professors Miratul Muqit and Dario Alessi
    21 Jun 2019

    The University of Dundee has today awarded an Honorary Doctorate to Dr Samantha Budd Haeberlein who is Vice President of Late Stage Clinical Development at Biogen. Samantha is a distinguished graduate of Dundee having obtained a First Class Honours Degree in Biochemistry in 1994 and then completing a PhD in 1997 under the supervision of David Nicholls FRS on the bioenergetics of neurons. Since then Samantha has flourished in the pharmaceutical industry over the last 20 years and emerged as a global leader in developing effective therapies against Alzheimer’s disease.

  • 19 Jun 2019

    The University of Dundee is one of the world’s top 100 universities for research quality, according to a major survey released today (June 19).

  •  Ian Kelsall and Jiazhen Zhang
    18 Jun 2019

    About 10 years ago, the discovery of the Linear Ubiquitin Assembly Complex (LUBAC) revolutionized our understanding of how the master transcription factor NF-kB was activated.  LUBAC a complex of the three proteins, HOIP, HOIL-1 and Sharpin, produces unique “linear” ubiquitin chains in which ubiquitins are joined to each other by peptide bonds.

  • Dr Kasper Rasmussen
    17 Jun 2019

    A Life Sciences scientist has been awarded £1.4 million from Cancer Research UK to develop research that could bring a ceasefire to cellular warfare taking place within our DNA that can cause blood cancers such as Leukaemia. Dr Kasper Rasmussen is one of only five researchers this year to have been awarded a prestigious Career Development Fellowship by the charity.

  • David Nicolls
    12 Jun 2019

    David Nicolls, a Principal Investigator at the University of Dundee from 1976 until 2000, has been elected  a Fellow of the Royal Society (FRS) for the ground breaking research that he carried out at Dundee over this period.

  • Ciulli Lab
    11 Jun 2019

    In an article published today in the prestigious journal Nature Chemical Biology, scientists at the University of Dundee and Boehringer Ingelheim have made an important first stride toward drugging undruggable cancer targets using an innovative approach to drug discovery.

  • Co-first authors Wei-Wei Kung, Sarath Ramachandran, and Nikolai Makukhin
    10 Jun 2019

    Researchers in the laboratory of Professor Alessio Ciulli have revealed atomic-resolution images of how an E3 ubiquitin ligase enzyme involved in immune and cell signalling latches on to its protein partners. This is important because these binding events are required for the protein to function properly inside the cell.

  • Drug Discovery Unit
    05 Jun 2019

    The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).